Page last updated: 2024-11-07

2-acetylaminofluorene and Carcinoma, Ehrlich Tumor

2-acetylaminofluorene has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yanokura, M1
Tsukada, K1

Other Studies

1 other study available for 2-acetylaminofluorene and Carcinoma, Ehrlich Tumor

ArticleYear
Decreased activities of glycine and guanidinoacetate methyltransferases and increased levels of creatine in tumor cells.
    Biochemical and biophysical research communications, 1982, Feb-26, Volume: 104, Issue:4

    Topics: 2-Acetylaminofluorene; Animals; Carcinoma, Ehrlich Tumor; Creatine; Glycine; Glycine N-Methyltransfe

1982